Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Taking two TRAILS.

Richard M Ransohoff1, Bruce D Trapp

  • 1Department of Neurosciences, Lerner Research Institute, The Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA. ransohr@ccf.org

Neuron
|May 11, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A transcriptomic microglia taxonomy across mouse and human pathologies.

Nature immunology·2026
Same author

Focused ultrasound-enhanced cell therapy for brain tumors: Summary of roundtable discussions.

Neuro-oncology advances·2026
Same author

Commensal <i>Escherichia coli</i> colonization triggers Peyer's patch development.

bioRxiv : the preprint server for biology·2025
Same author

Spatial protein profiling reveals active roles for astrocytes in the chronic active lesion core during multiple sclerosis.

Acta neuropathologica·2025
Same author

G-protein-coupled receptor ADGRG1 drives a protective microglial state in Alzheimer's disease through MYC activation.

Neuron·2025
Same author

Demyelinated lesion associated compartmental inflammation in progressive multiple sclerosis brains.

Acta neuropathologica communications·2025
Same journal

Sparse component analysis: A method that uncovers separable computations within neural population activity.

Neuron·2026
Same journal

Spatiomolecular mapping reveals anatomical organization of heterogeneous cell types in the human nucleus accumbens.

Neuron·2026
Same journal

TGF-β1-induced endothelial transcytosis drives blood-brain barrier leakage during aging.

Neuron·2026
Same journal

Image space opens up for visual neuroscience.

Neuron·2026
Same journal

Septal GLP-1 receptors control alcohol taking and seeking.

Neuron·2026
Same journal

Microglial fitness in moderation: Tuning TREM2 signaling through Ptpn6.

Neuron·2026
See all related articles

TNF-related apoptosis-inducing ligand (TRAIL) shows anti-inflammatory effects in autoimmune disease models but also causes neuronal death in the central nervous system. This suggests a need to control TRAIL activity in different body parts for therapeutic benefit.

Area of Science:

  • Neuroimmunology
  • Molecular Biology
  • Cell Death Pathways

Background:

  • The TNF-related apoptosis-inducing ligand (TRAIL) is known for its anti-inflammatory properties in autoimmune conditions like experimental autoimmune encephalomyelitis (EAE).
  • Previous research highlighted TRAIL's beneficial role in modulating immune responses within autoimmune disease models.

Discussion:

  • This study reveals a dual role for TRAIL in EAE: it possesses anti-inflammatory effects but concurrently triggers neuronal apoptosis within the central nervous system (CNS).
  • The findings indicate that TRAIL's impact is context-dependent, with different outcomes in the periphery versus the CNS.

Key Insights:

  • TRAIL mediates both beneficial anti-inflammatory actions and detrimental neurotoxic effects in the EAE model.
  • Selective modulation of TRAIL activity is crucial, requiring enhanced expression in the periphery and inhibition within the CNS.

Related Experiment Videos

Outlook:

  • Future therapeutic strategies for autoimmune neurological diseases may involve targeting TRAIL signaling pathways.
  • Developing methods to differentiate peripheral and CNS TRAIL effects could lead to novel treatment approaches for EAE and similar conditions.